Amarincorp.com

BOLD Science to Drive Forward Cardiovascular Health

WebThe science behind the development of CVD is complex. We seek to improve the lives of people who are at risk of strokes, heart attacks and other serious CVD events. We do …

Actived: 7 days ago

URL: https://amarincorp.com/science-health

What is Cardiovascular Disease

WebThe first step in better cardiometabolic health. Cardiovascular disease (CVD) is a major health problem, affecting millions of people globally. From hereditary conditions and lifestyle habits to societal and environmental …

Category:  Health Go Health

Our Products Amarin Corp plc

WebLEADING A NEW PARADIGM IN CARDIOVASCULAR HEALTH. The science behind the development of cardiovascular disease is complex. Our current treatment targets …

Category:  Health Go Health

Amarin Corp plc Home Clinical Stage pharmaceutical Company

WebAmarin Corporation is a rapidly growing innovative pharmaceutical company, focused on developing and pursuing additional therapeutics to cost-effectively address …

Category:  Health Go Health

Latest Research Evaluating VASCEPA®/VAZKEPA® (icosapent …

WebForward-Looking Statements This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of the Private …

Category:  Health Go Health

Amarin Takes Proactive Steps to Support Public Health Priorities

WebAccordingly, as Amarin is intently focused on improving public health by reducing cardiovascular risk, currently the most damaging disease in the industrialized world, and …

Category:  Health Go Health

The Latest News and Press Releases

WebThe press releases contained in this section of the website are provided for historical purposes only. The information contained in each press release is accurate only as of …

Category:  Health Go Health

Amarin And Neopharm Announce Exclusive Commercialization …

WebThe agreement follows Israel’s Ministry of Health (MOH) Pharmaceuticals Division granting regulatory approval to VAZKEPA (icosapent ethyl). The MOH issued its …

Category:  Health Go Health

Amarin Outlines New Go-to-Market Strategy to Accelerate …

WebEnables Amarin to Drive Additional Demand, Improve Patient Access & Education and Secure Proper Fulfillment and Reimbursement. DUBLIN, Ireland and …

Category:  Health Go Health

Mission, Vision and Values Vision Amarin Corp plc

WebAt Amarin, we’re focused on stopping cardiovascular disease (CVD) from being a leading cause of death. We believe that CVD patients, their loved ones, and society as a whole …

Category:  Health Go Health

JAMA Publication Highlights VASCEPA® (Icosapent Ethyl) …

WebThe costs utilized for IPE in the model included a publicly available SSR Health net cost of $4.16 per day after rebates, and the wholesale acquisition cost of …

Category:  Health Go Health

Amarin to Present at the 40th Annual J.P. Morgan Healthcare …

WebDUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that Karim …

Category:  Health Go Health

Amarin Provides Pricing & Reimbursement Updates for VAZKEPA …

WebIn the Netherlands, the Dutch Ministry of Health has approved VAZKEPA ® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular events …

Category:  Health Go Health

NICE Issues Final Guidance for Reimbursement

Web-- Newly published final guidance by the National Institute for Health and Care Excellence (NICE) in the UK confirms its prior draft recommendation for the use of …

Category:  Health Go Health

Amarin Announces Vascepa® (Icosapent Ethyl) Approved to …

WebBoth the Saudi National Diabetes Center (SNDC) and The National Heart Center (NHC) in their published guidelines for diabetes and dyslipidemia, under the Saudi Health Council …

Category:  Health Go Health

Amarin to Present at the 41st Annual J.P. Morgan Healthcare …

WebDUBLIN, Ireland and BRIDGEWATER, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim …

Category:  Health Go Health

Step Inside the World of Amarin Working at Amarin Amarin …

WebA new paradigm in cardiovascular health management Amarin Corporation is focused on a BOLD vision to stop cardiovascular disease from being a leading cause of death. Find …

Category:  Health Go Health

Amarin Reports Third Quarter 2023 Financial Results

WebIn Europe revenue was $0.8 million in the third quarter of 2023. Amarin recognized licensing and royalty revenue of $1.2 million and $0.7 million during the three …

Category:  Health Go Health

Amarin to Present at 39th Annual J.P. Morgan Healthcare Conference

WebDUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) announced today that John F. …

Category:  Health Go Health

J.P. Morgan Healthcare Conference Amarin Global

WebAbout Amarin for Investors. Amarin is a leading cardiovascular health pharmaceutical company. As leaders, we apply science, research, passion and global …

Category:  Health Go Health

Amarin to Present at 38th Annual J.P. Morgan Healthcare Conference

WebDUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) announced today that John F. …

Category:  Health Go Health

Company Location Information Where We Are Amarin Corp plc

WebFocused on a new paradigm in cardiovascular health, Amarin has a significant presence in the U.S. market as well as in key European countries to bring new hope to those …

Category:  Health Go Health